| OR | 95% CI | p-value a |
---|---|---|---|
Sex (reference: Female) | |||
 Male | 1.61 | 1.22–2.11 | < 0.001 |
Tumor site (reference: Upper limbs) | |||
 Lower limbs | 0.88 | 0.55–1.42 | 0.602 |
 Head | 1.98 | 1.19–3.30 | 0.009 |
 Hands/feet | 2.18 | 1.14–4.18 | 0.019 |
 Trunk | 0.68 | 0.45–1.01 | 0.058 |
Histologic subtype (reference: Nodular melanoma) | |||
 Superficial spreading | 0.85 | 0.54–1.33 | 0.470 |
 Other | 0.88 | 0.48–1.61 | 0.673 |
Growth type (reference: Radial) | |||
 Vertical | 1.11 | 0.78–1.57 | 0.555 |
Mitotic count per high power microscopic field | |||
 | 1.05 | 1.01–1.08 | 0.011 |
Tumor infiltrating lymphocytes (reference: Present) | |||
 Absent | 1.32 | 0.99–1.76 | 0.063 |
TNM Stage (reference: stage I) | |||
 II | 2.77 | 1.79–4.30 | < 0.001 |
 III | 1.13 | 0.70–1.83 | 0.623 |
 IV | 1.40 | 0.55–3.58 | 0.482 |